A Smart Drug Delivery Platform
Peptinovo’s patented technology offers a smart drug delivery platform designed to improve the efficacy of a variety of proven, approved chemotherapies on a broad range of solid tumors while greatly reducing the serious side effects that limit chemotherapy success.
Our Promising Pipeline is Set to Change Cancer Treatment
We are currently completing pre-IND enabling testing on our first drug, PNB-281 (our PALM™ carrier with the industry-leading chemotherapy Paclitaxel). Four additional chemotherapy drugs have been developed and are ready to enter pre-IND.
A Team of Proven Industry Veterans
Peptinovo’s seasoned team has launched three drugs from idea to market, started seven individual pharma companies with 3 exits and 4 ongoing compaines, and led all aspects needed to develop, test, and launch pharmacology products.
